{
    "2019-07-17": [
        [
            {
                "time": "2019-07-18",
                "original_text": "Pre-Market Earnings Report for July 18, 2019: UNH, HON, PM, UNP, DHR, MS, TSM, BBT, BX, NVS, STI, PPG",
                "features": {
                    "keywords": [
                        "earnings report",
                        "pre-market",
                        "NVS"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-18",
                "original_text": "Why Earnings Season Could Be Great for Novartis (NVS)",
                "features": {
                    "keywords": [
                        "earnings season",
                        "Novartis",
                        "great"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-18",
                "original_text": "Mallinckrodt (MNK) Discontinues Sclerosis Study on Acthar Gel",
                "features": {
                    "keywords": [
                        "discontinues",
                        "sclerosis study",
                        "Acthar Gel"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-18",
                "original_text": "Merck's Antibiotic Recarbrio Gets FDA Nod for Infections",
                "features": {
                    "keywords": [
                        "FDA nod",
                        "antibiotic",
                        "Recarbrio"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-18",
                "original_text": "Trade Talk Cools Off Record-Setting Market",
                "features": {
                    "keywords": [
                        "trade talk",
                        "record-setting market",
                        "cools off"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy",
                        "global trade"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-18",
                "original_text": "Should You Pick Up Novartis (NVS) Before Q2 Earnings?",
                "features": {
                    "keywords": [
                        "pick up",
                        "Q2 earnings",
                        "NVS"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-18",
                "original_text": "The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On",
                "features": {
                    "keywords": [
                        "gene therapy",
                        "manufacturing",
                        "race"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}